There are a lot of innovations that have created substantial benefits for large groups of people in the Western World. It is not obvious that the same innovations can create the same benefits in the developing world. Technology development has been focusing on products that can be profitably sold, the market-driven development mainly benefits the rich because the rich has much bigger purchasing power than the poor.
Nestle and the Marketing of Baby-Milk Formula in Africa
The history of Nestle is connected to the invention of infant formula. Henri Nestle, the founder of the company developed the modern form of baby-milk substitute more than 100 years ago. First, the formula targeted upper-middle class women in Europe, in particular mothers who were not able to breast-feed their babies. The product was also marketed in USA, and after some time the promotion of the product became so successful that by the end of 1960s only 25 % of babies born in North American hospitals were breast-fed after their mothers returned home. However, there has been a strong evidence that breast feeding is superior to any kind of milk substitutes from a health and nourishment point of view.
When birth rates began to decrease in industrialized countries, Third World countries became an attractive market for baby-milk substitute products. In the late 1970s, Nestlé received much criticism for its baby milk marketing policies in developing countries. This cantered on the company's promotion strategies which presented Nestlé milk substitutes as a risk free, healthy product which is more beneficial than breast milk. As a result, mothers who might otherwise have breastfed or nursed started using Nestle's infant formula products. The babies then exposed to widespread health problems caused by mixing formula with contaminated water. UNICEF estimated that a non-breastfed child living in disease-ridden and non-hygienic environment is between six to 25 times more likely to die of diarrhoea and four times more likely to die of pneumonia than a breastfed child. Sethi (1994) and Post (1995) .)
River Blindness and Merck & Co.
Merck & Co. is an American drug company with a worldwide sale of USD 2 billion a year. In 1977 a researcher who worked for the company, discovered that an animal drug, Ivermectin, might eradicate the parasites that cause river blindness. The question soon became pressing;
should the company work further in order to develop and produce the medicine for humans in large quantities to cure river blindness? (Velasquez 1998 , Weiss and Bollier 2013 , and Musings 2012 River blindness is a serious disease that affects more than 80 million people in tropical regions of Africa and Latin America. The disease is also known as Robles' disease, and is caused by a parasitic roundworm which is transmitted to a person through the bite of a black fly. The worm grows inside a human's skin in a circular shape, reaching up to two centimeter in diameter. The worm also reproduces by releasing millions of microscopic bacteria called microfilia that cause intense lesions and itching and ultimately blindness. The itching in itself has been so tedious that infected persons have committed suicide.
The people who effected by this disease are typically living in remote villages. They are very poor and their purchasing power is almost zero. There is therefore no prospect for making a profit in the ordinary sense with developing and marketing such a medicine for these people.
Scientist William Cambell and his research team appealed to Merck's Chairman P. Roy Vagelos to receive a funding for developing the drug. The Merck top management was faced with a number of issues including -The cost of research and development of the drug would be more than USD 100 million while the prospect for profit is minimal because the victims in general were too poor to afford to pay for the drug.
-The distribution of the drug requires a huge investment in infrastructure and distribution channels.
-The reputation of Merck would be negative if the drug did not have the intended effect on people, and this impact might reduce the sales of the animal version of the drug.
-The US Congress was about to pass the Drug Regulation Act, which shortens the time for patens, and in effect increase the competition in the drug industry.
These conditions were not favourable for the funding of the river blindness drug project.
However after several meetings, Merck's Chairman, Vagelos concluded that the project should be funded due to the moral obligation to the affected people in spite of the costs and the little chance of making a profit. The potential benefits of a drug for river blindness were too significant to ignore. The main argument to support the project was Merck's celebrated credo: "Medicine is for the people. It is not for the profits. The profits follow".
After seven years of research and a number of clinical trials, Merck had developed a medicine that was able to eliminate the parasite that cause river blindness and prevent new infections.
The next stage was to sell the pill and Merck's officials contacted World Health Organization, the US Government, and the governments of nations affected by the disease in order to have compensation for the production of the pills.
Merck then decided that the drug should be free for the victims of the disease. But which distribution channel can be used? In cooperation with WHO, representatives of Merck financed an international committee to provide the necessary infrastructure for distributing the drug to people in the developing countries.
By 1996, the drug was successfully brought to millions of affected people through the help of voluntary organizations and governments.
Microfinance by the Grameen Bank
The idea of microfinance is that poor people, especially women, should be provided with financial capital upon reasonable terms. In this way poor people could avoid high usury charges. By the lending small amount of loans ('microloans') to poor people they could realize their dreams, for example starting a small business or earn some income. The need was to develop a new type of banking and providing a safe place to keep the borrowers money.
One way was to develop a system of community banking where small informal groups can do business with the banks.
The idea of microcredit has been developed by Mohammad Yunus, the founder of Grameen Bank in Bangladesh. The underlying premises is that the poor have skills that are either nonutilized or under-utilized. What make people poor are not the lack of skills, but the institutions that prevails in the society. (Yunus 2011) To eliminate poverty in the society, it is necessary to change the institutional context. The paradox of help is taken into consideration, which means that charity is not the best means to avoid poverty, because it may become counterproductive. Charity usually create a vicious circle of dependency which may destroy personal responsibility and initiatives. The answer is "fitting help", that is, providing people with the adequate means to help themselves, which increase their self-esteem and unleash their energy and creativity. (Ims and Jacobsen 2010, 170-171) Solidarity lending is a cornerstone of Grameen Bank. Although each borrower must belong to a five-member group, the group is not required to give any guarantee for the loan received by its members. Repayment responsibility solely rests on the individual borrower, while the group and the centre oversee that everyone behaves in a responsible way and none gets into a repayment problem. Such behavior is facilitated by Grameen's policy of not extending any further credit to a group in which a member defaults.
There is no written contract between Grameen Bank and its borrowers, the system works on trust. To supplement the lending, Grameen Bank also requires the borrowing members to save very small amounts regularly in a number of funds like emergency fund, group fund etc. These savings help serve as an insurance against contingencies. (Yunus 2011) 
Fair Trade by Max Havelaar
The 21 st century global economy has created massive market driven social changes, and big corporations take the lead the development often characterized as 'race to the bottom' in which corporations in many cases exploit the low-cost countries. One result is reduced biodiversity and millions of poor producers in the world caught in poverty trap.
In the 1950s a partnership started between non-profit importers and retailers in the North and small-scale producers in the South. The idea was that local producers need a fair income, and bypassing the middlemen they can get direct access to markets in the developed countries. In 1988 a Dutch NGO, Solidaridad developed an innovative way to increase sales for the local small producers of the South. They created a label, called "Max Havelaar" which guaranteed that the goods met certain environmental and labor standards. 
Discussion
What was wrong with Nestlé's marketing strategy? In the Third World the fittingness of the product in the targeted social environment is crucial. Marketing techniques should not exploit the vulnerability of the customers. Nestle did not use post-marketing reviews to monitor the use, resale, and consumption of its products, and did not consider the strategy of demarketing, that is to withdraw of the product or to limit the selling of the product when needed. (Post 1995) In his book "The Market for Virtue" David Vogel (2005) We summarize important similarities and differences among the four cases analysed in the paper by using variables such as goals, means and skills/resources needed for adopting a technology. Our findings are summarized in Table 1 .
(insert Table 1 here)
Concluding remark
We have studied fair trade, microfinance and Merck and Co. as examples of social innovations that improved the life conditions of the poor in the developing countries. We contrasted these cases with Nestle marketing of the baby milk formula in Africa. Unlike the Nestle case, none of the exemplary social innovation cases involves profit as the primary goal but emphasize social, spiritual and humanitarian goals such as minimizing suffering and empowering people and communities.
The business models of the Bottom of the Pyramid (BoP) approach (Prahalad 2004, Hart and London 2005) receive worldwide recognition today. BoP means developing innovative businesses to serve the largest, but poorest socio-economic group in the world. In global terms, this is about four billion people who live on less than USD 2.50 per day. However, we can predict that if BoP businesses do not transcend the logic of mainstream, materialistic business they will finally fail. Sensitivity to local cultural needs and an ethos for serving the common good appear as the preconditions of any successful and lasting social innovation by business.
